Repare Therapeutics Stock Shares Outstanding
| RPTX Stock | USD 3.32 0.17 5.40% |
Repare Therapeutics fundamentals help investors to digest information that contributes to Repare Therapeutics' financial success or failures. It also enables traders to predict the movement of Repare Stock. The fundamental analysis module provides a way to measure Repare Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Repare Therapeutics stock.
Common Stock Shares Outstanding is likely to drop to about 35.7 M in 2024. Repare | Shares Outstanding |
Repare Therapeutics Company Shares Outstanding Analysis
Repare Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Repare Therapeutics Shares Outstanding | 42.51 M |
Most of Repare Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Repare Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Repare Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Repare Therapeutics is extremely important. It helps to project a fair market value of Repare Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Repare Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Repare Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Repare Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Repare Shares Outstanding Historical Pattern
Today, most investors in Repare Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Repare Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Repare Therapeutics shares outstanding as a starting point in their analysis.
Repare Therapeutics Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Repare Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Repare Therapeutics has 42.51 M of shares currently outstending. This is 76.45% lower than that of the Biotechnology sector and 60.22% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 92.57% higher than that of the company.
Repare Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Repare Therapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Repare Therapeutics could also be used in its relative valuation, which is a method of valuing Repare Therapeutics by comparing valuation metrics of similar companies.Repare Therapeutics is currently under evaluation in shares outstanding category among its peers.
Repare Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Repare Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Repare Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Repare Fundamentals
| Return On Equity | -0.41 | ||||
| Return On Asset | -0.23 | ||||
| Profit Margin | (1.26) % | ||||
| Operating Margin | (1.39) % | ||||
| Current Valuation | (42.96 M) | ||||
| Shares Outstanding | 42.51 M | ||||
| Shares Owned By Insiders | 0.95 % | ||||
| Shares Owned By Institutions | 83.62 % | ||||
| Number Of Shares Shorted | 749.74 K | ||||
| Price To Book | 0.77 X | ||||
| Price To Sales | 2.01 X | ||||
| Revenue | 51.13 M | ||||
| Gross Profit | 15.11 M | ||||
| EBITDA | (114.27 M) | ||||
| Net Income | (93.8 M) | ||||
| Cash And Equivalents | 282.09 M | ||||
| Cash Per Share | 6.73 X | ||||
| Total Debt | 3.41 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 7.35 X | ||||
| Book Value Per Share | 4.12 X | ||||
| Cash Flow From Operations | (127.16 M) | ||||
| Short Ratio | 7.12 X | ||||
| Earnings Per Share | (1.99) X | ||||
| Target Price | 12.5 | ||||
| Number Of Employees | 179 | ||||
| Beta | 0.71 | ||||
| Market Capitalization | 133.91 M | ||||
| Total Asset | 253.9 M | ||||
| Retained Earnings | (333.11 M) | ||||
| Working Capital | 204.61 M | ||||
| Net Asset | 253.9 M |
About Repare Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Repare Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Repare Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Repare Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Repare Stock Analysis
When running Repare Therapeutics' price analysis, check to measure Repare Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repare Therapeutics is operating at the current time. Most of Repare Therapeutics' value examination focuses on studying past and present price action to predict the probability of Repare Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repare Therapeutics' price. Additionally, you may evaluate how the addition of Repare Therapeutics to your portfolios can decrease your overall portfolio volatility.